Global Drug Discovery Services Market Size study & Forecast, by Process, by Type, by Drug Type, by Therapeutic Area, by End User, and Regional Analysis, 2023-2030

Description

List of Tables

Global Drug Discovery Services Market is valued approximately USD 17.9 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2023-2030. Drug discovery services encompass a range of scientific and technological solutions provided by specialized organizations to support the identification, development, and optimization of new drug candidates. These services involve various stages of the drug discovery process, including target identification and validation, high-throughput screening, hit-to-lead optimization, medicinal chemistry, ADME (absorption, distribution, metabolism, and excretion) studies, and preclinical development. Through a combination of expertise, advanced technologies, and research methodologies, drug discovery services aim to accelerate the discovery and development of safe and effective drugs, ultimately advancing healthcare and addressing unmet medical needs. The market drivers boosting the market growth are increasing R&D expenditure and growing prevalence of chronic diseases.

According to Statista, in 2022, the total spending on pharmaceutical R&D accounted to USD 238 billion and is expected to amount to USD 285 billion in 2028. The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a significant need for innovative and effective drug therapies. According to Statista, the cancer deaths worldwide are projected to rise from nearly 10 million in 2022 to over 16 million by 2040. Moreover, expansion of Biologics and Cell-Based therapies and increasing demand for personalized medicines may create lucrative opportunities. However, the high cost of Drug Discovery and limited availability of skilled workforce stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Discovery Services Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to a well-established pharmaceutical sector, ongoing research and development projects, significant R&D spending, expansion of the biosimilar and generics markets, and increasing outsourcing of R&D services by pharmaceutical and biopharmaceutical companies in the region. However, Asia Pacific is expected to become the fastest growing during the forecast period, owing to factors such as growing pharmaceutical industry, and increasing outsourcing drug discovery activities to specialized service providers to streamline operations, reduce costs, and access specialized expertise.

Major market player included in this report are:

Laboratory Corporation of America Holdings
Charles River Laboratories International, Inc.
Eurofins Scientific SE
GVK Biosciences Private Limited
Albany Molecular Research Inc. (AMRI)
Domainex Ltd.
GenScript Biotech Corporation
Aurigene Discovery Technologies Ltd.
WuXi AppTec
Evotec SE

Recent Developments in the Market:

In February 2023, Evotec SE and Related Sciences have extended their collaborative partnership to pursue an integrated multi-target drug discovery agreement. Their joint objective is to identify, research, and advance highly targeted therapies to address unmet medical requirements.
In January 2023, Charles River Laboratories completed the acquisition of SAMDI Tech, Inc., a provider of label-free high-throughput screening (HTS) solutions for drug discovery research. This acquisition enhances Charles River Laboratories' capabilities in label-free HTS MS platforms and expands its portfolio of drug discovery solutions, resulting in a comprehensive library of offerings.

Global Drug Discovery Services Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Process, Type, Drug Type, Therapeutic Area, End User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Process:

Target Selection
Target Validation
Hit-to-Lead Identification
Lead Optimization
Candidate Validation

By Type:

Chemistry Services
Biology Services

By Drug Type:

Small-Molecule Drugs
Biologics

By Therapeutic Area:

Oncology
Infectious Diseases
Neurological Diseases
Immunological Diseases
Endocrine and Metabolic Diseases
Respiratory Diseases
Digestive System Diseases
Cardiovascular Diseases
Genitourinary Diseases
Other Therapeutic Area

By End User:

Pharmaceutical & Biotechnology Companies
Academic Institutes
Other End Users

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Drug Discovery Services Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Drug Discovery Services Market, by Process, 2020-2030 (USD Billion)
- 1.2.3. Drug Discovery Services Market, by Type, 2020-2030 (USD Billion)
- 1.2.4. Drug Discovery Services Market, by Drug Type, 2020-2030 (USD Billion)
- 1.2.5. Drug Discovery Services Market, by Therapeutic Area, 2020-2030 (USD Billion)
- 1.2.6. Drug Discovery Services Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Drug Discovery Services Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Services Market Dynamics

3.1. Drug Discovery Services Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing R&D expenditure
  - 3.1.1.2. Growing prevalence of chronic diseases
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Drug Discovery
  - 3.1.2.2. Limited availability of skilled workforce
- 3.1.3. Market Opportunities
  - 3.1.3.1. Expansion of Biologics and Cell-Based Therapies
  - 3.1.3.2. Increasing demand for personalized medicine

Chapter 4. Global Drug Discovery Services Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Services Market, by Process

5.1. Market Snapshot
5.2. Global Drug Discovery Services Market by Process, Performance - Potential Analysis
5.3. Global Drug Discovery Services Market Estimates & Forecasts by Process 2020-2030 (USD Billion)
5.4. Drug Discovery Services Market, Sub Segment Analysis
- 5.4.1. Target Selection
- 5.4.2. Target Validation
- 5.4.3. Hit-to-Lead Identification
- 5.4.4. Lead Optimization
- 5.4.5. Candidate Validation

Chapter 6. Global Drug Discovery Services Market, by Type

6.1. Market Snapshot
6.2. Global Drug Discovery Services Market by Type, Performance - Potential Analysis
6.3. Global Drug Discovery Services Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
6.4. Drug Discovery Services Market, Sub Segment Analysis
- 6.4.1. Chemistry Services
- 6.4.2. Biology Services

Chapter 7. Global Drug Discovery Services Market, by Drug Type

7.1. Market Snapshot
7.2. Global Drug Discovery Services Market by Drug Type, Performance - Potential Analysis
7.3. Global Drug Discovery Services Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
7.4. Drug Discovery Services Market, Sub Segment Analysis
- 7.4.1. Small-Molecule Drugs
- 7.4.2. Biologics

Chapter 8. Global Drug Discovery Services Market, by Therapeutic Area

8.1. Market Snapshot
8.2. Global Drug Discovery Services Market by Therapeutic Area, Performance - Potential Analysis
8.3. Global Drug Discovery Services Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Billion)
8.4. Drug Discovery Services Market, Sub Segment Analysis
- 8.4.1. Oncology
- 8.4.2. Infectious Diseases
- 8.4.3. Neurological Diseases
- 8.4.4. Immunological Diseases
- 8.4.5. Endocrine and Metabolic Diseases
- 8.4.6. Respiratory Diseases
- 8.4.7. Digestive System Diseases
- 8.4.8. Cardiovascular Diseases
- 8.4.9. Genitourinary Diseases
- 8.4.10. Other Therapeutic Area

Chapter 9. Global Drug Discovery Services Market, by End User

9.1. Market Snapshot
9.2. Global Drug Discovery Services Market by End User, Performance - Potential Analysis
9.3. Global Drug Discovery Services Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
9.4. Drug Discovery Services Market, Sub Segment Analysis
- 9.4.1. Pharmaceutical & Biotechnology Companies
- 9.4.2. Academic Institutes
- 9.4.3. Other End Users

Chapter 10. Global Drug Discovery Services Market, Regional Analysis

10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Drug Discovery Services Market, Regional Market Snapshot
10.4. North America Drug Discovery Services Market
- 10.4.1. U.S. Drug Discovery Services Market
  - 10.4.1.1. Process breakdown estimates & forecasts, 2020-2030
  - 10.4.1.2. Type breakdown estimates & forecasts, 2020-2030
  - 10.4.1.3. Drug Type breakdown estimates & forecasts, 2020-2030
  - 10.4.1.4. Therapeutic Area breakdown estimates & forecasts, 2020-2030
  - 10.4.1.5. End User breakdown estimates & forecasts, 2020-2030
- 10.4.2. Canada Drug Discovery Services Market
10.5. Europe Drug Discovery Services Market Snapshot
- 10.5.1. U.K. Drug Discovery Services Market
- 10.5.2. Germany Drug Discovery Services Market
- 10.5.3. France Drug Discovery Services Market
- 10.5.4. Spain Drug Discovery Services Market
- 10.5.5. Italy Drug Discovery Services Market
- 10.5.6. Rest of Europe Drug Discovery Services Market
10.6. Asia-Pacific Drug Discovery Services Market Snapshot
- 10.6.1. China Drug Discovery Services Market
- 10.6.2. India Drug Discovery Services Market
- 10.6.3. Japan Drug Discovery Services Market
- 10.6.4. Australia Drug Discovery Services Market
- 10.6.5. South Korea Drug Discovery Services Market
- 10.6.6. Rest of Asia Pacific Drug Discovery Services Market
10.7. Latin America Drug Discovery Services Market Snapshot
- 10.7.1. Brazil Drug Discovery Services Market
- 10.7.2. Mexico Drug Discovery Services Market
10.8. Middle East & Africa Drug Discovery Services Market
- 10.8.1. Saudi Arabia Drug Discovery Services Market
- 10.8.2. South Africa Drug Discovery Services Market
- 10.8.3. Rest of Middle East & Africa Drug Discovery Services Market

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
- 11.1.1. Company 1
- 11.1.2. Company 2
- 11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Laboratory Corporation of America Holdings
  - 11.3.1.1. Key Information
  - 11.3.1.2. Overview
  - 11.3.1.3. Financial (Subject to Data Availability)
  - 11.3.1.4. Product Summary
  - 11.3.1.5. Recent Developments
- 11.3.2. Charles River Laboratories International, Inc.
- 11.3.3. Eurofins Scientific SE
- 11.3.4. GVK Biosciences Private Limited
- 11.3.5. Albany Molecular Research Inc. (AMRI)
- 11.3.6. Domainex Ltd.
- 11.3.7. GenScript Biotech Corporation
- 11.3.8. Aurigene Discovery Technologies Ltd.
- 11.3.9. WuXi AppTec
- 11.3.10. Evotec SE

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Drug Discovery Services Market, report scope
TABLE 2. Global Drug Discovery Services Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Drug Discovery Services Market estimates & forecasts by Process 2020-2030 (USD Billion)
TABLE 4. Global Drug Discovery Services Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 5. Global Drug Discovery Services Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
TABLE 6. Global Drug Discovery Services Market estimates & forecasts by Therapeutic Area 2020-2030 (USD Billion)
TABLE 7. Global Drug Discovery Services Market estimates & forecasts by End User 2020-2030 (USD Billion)
TABLE 8. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 18. U.S. Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. U.S. Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. U.S. Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. Canada Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. Canada Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. UK Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. UK Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. Germany Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. Germany Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. France Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. France Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Italy Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Italy Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. Spain Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. Spain Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. RoE Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. RoE Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. China Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. China Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. India Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. India Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. Japan Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. Japan Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. South Korea Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. South Korea Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. Australia Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. Australia Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. RoAPAC Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. RoAPAC Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Brazil Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Brazil Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. Mexico Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. Mexico Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. RoLA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoLA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. Saudi Arabia Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 70. South Africa Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 71. RoMEA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 72. List of secondary sources, used in the study of global Drug Discovery Services Market
TABLE 73. List of primary sources, used in the study of global Drug Discovery Services Market
TABLE 74. Years considered for the study
TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Drug Discovery Services Market, research methodology
FIG 2. Global Drug Discovery Services Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Drug Discovery Services Market, key trends 2022
FIG 5. Global Drug Discovery Services Market, growth prospects 2023-2030
FIG 6. Global Drug Discovery Services Market, porters 5 force model
FIG 7. Global Drug Discovery Services Market, pest analysis
FIG 8. Global Drug Discovery Services Market, value chain analysis
FIG 9. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Drug Discovery Services Market, regional snapshot 2020 & 2030
FIG 15. North America Drug Discovery Services Market 2020 & 2030 (USD Billion)
FIG 16. Europe Drug Discovery Services Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Drug Discovery Services Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Drug Discovery Services Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Drug Discovery Services Market 2020 & 2030 (USD Billion)